
Data Compilation Highlights Potential of SON-1010 to Enhance Therapeutic Efficacy in Solid Tumors
SON-1010 (IL-12-FHAB), an IL-12–based immunotherapy, is being investigated for its potential to improve treatment efficacy in patients with solid tumors, either as a monotherapy or in combination with other agents. Compiled data presented at the 2025 AACR …